AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
EV to Sales HistoryNormalizing
Percentile Rank57
3Y CAGR+8.5%
5Y CAGR+12.0%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+8.5%/yr
vs -8.5%/yr prior
5Y CAGR
+12.0%/yr
Recent deceleration
Acceleration
+17.0pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
20252.08-11.7%
20242.36+87.8%
20231.26-23.0%
20221.63-21.6%
20212.08+75.7%
20201.19-55.0%
20192.63+13.3%
20182.33-18.1%
20172.84-17.9%
20163.46-